Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilya Glezerman

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
American Journal of Hematology|July 2, 2019
Monoclonal gammopathy-associated thrombotic microangiopathyJennifer C Yui, Daniel Garceau, Kenar D Jhaveri, et al.
Nature Reviews. Nephrology|March 31, 2021
Kidney injury and disease in patients with haematological malignanciesFrank Bridoux, Paul Cockwell, Ilya Glezerman, et al.
Cytotherapy|November 5, 2025
Pilot study of early BK polyomavirus in the urine and risk of hemorrhagic cystitis after allogeneic hematopoietic cell transplantationYeon Joo Lee, Yuxuan Li, Michael Scordo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Cancer immunotherapy-related adverse events: causes and challengesAda G Blidner, Jennifer Choi, Tim Cooksley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitorsMichael Dougan, Ada G Blidner, Jennifer Choi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicityVickie R Shannon, Ronald Anderson, Ada Blidner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitorsJennifer Choi, Ronald Anderson, Ada Blidner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2020
Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood TransplantationVictoria Gutgarts, Insara Jaffer Sathick, Junting Zheng, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicitiesTim Cooksley, Monica Girotra, Pamela Ginex, et al.
Clinical Genitourinary Cancer|June 15, 2015
Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell TumorsDarren R Feldman, Ilya Glezerman, Sujata Patil, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
American Journal of Hematology|July 2, 2019
Monoclonal gammopathy-associated thrombotic microangiopathyJennifer C Yui, Daniel Garceau, Kenar D Jhaveri, et al.
Nature Reviews. Nephrology|March 31, 2021
Kidney injury and disease in patients with haematological malignanciesFrank Bridoux, Paul Cockwell, Ilya Glezerman, et al.
Cytotherapy|November 5, 2025
Pilot study of early BK polyomavirus in the urine and risk of hemorrhagic cystitis after allogeneic hematopoietic cell transplantationYeon Joo Lee, Yuxuan Li, Michael Scordo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Cancer immunotherapy-related adverse events: causes and challengesAda G Blidner, Jennifer Choi, Tim Cooksley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitorsMichael Dougan, Ada G Blidner, Jennifer Choi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicityVickie R Shannon, Ronald Anderson, Ada Blidner, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitorsJennifer Choi, Ronald Anderson, Ada Blidner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2020
Incidence and Risk Factors for Acute and Chronic Kidney Injury after Adult Cord Blood TransplantationVictoria Gutgarts, Insara Jaffer Sathick, Junting Zheng, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicitiesTim Cooksley, Monica Girotra, Pamela Ginex, et al.
Clinical Genitourinary Cancer|June 15, 2015
Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell TumorsDarren R Feldman, Ilya Glezerman, Sujata Patil, et al.
Pageof 3